NEIL WILSON: Open Payments
NPI 1295319531 · OLYMPIA FIELDS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 10 payments from 7 companies in 2025. Trend: 2023 $149 · 2024 $0 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $462 |
| Teva Pharmaceuticals USA, Inc. | 2 | $219 |
| Braeburn Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| Janssen Pharmaceuticals, Inc | 1 | $111 |
| Axsome Therapeutics, Inc. | 1 | $105 |
Products named: INGREZZA, UZEDY, BRIXADI, CAPLYTA, REXULTI, SPRAVATO, Auvelity.
Industry payments across IL — which companies pay providers there.
